Citi lowered the firm’s price target on AvePoint (AVPT) to $16 from $18 and keeps a Neutral rating on the shares. The firm says the company’s ...

AvePoint has a 12 month low of $7.08 and a 12 month high of $19.90. Institutional Trading of AvePoint A number of large investors have recently made changes to their positions in the stock.

Business Insider's personal finance team compared College Ave to the best private student loans and found it to be an industry leader. Not only is College Ave known for having competitive interest ...

Sign up for our newsletter to get the latest on the transformative forces shaping the global economy, delivered every Thursday.

Handelsbanken Fonder AB purchased a new position in shares of AvePoint, Inc. (NASDAQ:AVPT – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC.

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Friday, shares of AvePoint Inc (Symbol: AVPT) entered into oversold territory, hitting an RSI reading of 28.8 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

“Our fourth quarter was an outstanding close to 2024, and we are pleased with the team’s steady focus and broad-based execution,” said Dr. Tianyi Jiang (TJ), CEO and Co-Founder, AvePoint.

Include popular icons in your React projects easily with react-icons, which utilizes ES6 imports that allows you to include only the icons that your project is using. For example, to use an icon from ...

JERSEY CITY, N.J. - AvePoint, Inc. (NASDAQ:AVPT) shares plunged 13.6% after the data security and governance firm reported mixed fourth-quarter results, with earnings falling short of analyst ...

“Our fourth quarter was an outstanding close to 2024, and we are pleased with the team’s steady focus and broad-based execution,” said Dr. Tianyi Jiang (TJ), CEO and Co-Founder, AvePoint. “Our results ...